Page last updated: 2024-10-28

ifenprodil and Dyskinesia, Drug-Induced

ifenprodil has been researched along with Dyskinesia, Drug-Induced in 1 studies

ifenprodil: NMDA receptor antagonist

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konitsiotis, S1
Tsironis, C1
Kiortsis, DN1
Evangelou, A1

Other Studies

1 other study available for ifenprodil and Dyskinesia, Drug-Induced

ArticleYear
Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias.
    Psychopharmacology, 2006, Volume: 185, Issue:3

    Topics: Allosteric Regulation; Amantadine; Animals; Antipsychotic Agents; Dextrorphan; Dose-Response Relatio

2006